Semaglutide is normally properly tolerated with comparable dropout rates compared with placebo, although it may very well be considerably less nicely tolerated than dulaglutide (Trulicity).one,3 The commonest adverse results are nausea, vomiting, and diarrhea and will be experienced by about thirty% of sufferers, normally if the dose is increased.D